Back to lessons
Monoclonal antibodies and immune-modulating therapies
Watch the video here for free, with no account or subscription. Try a sample question; membership adds the companion chapter and full quiz.
Free video · no account needed · 17 minutesWatch on YouTube
CONTINUE THIS LESSON
Read deeper. Practice the reasoning.
The video above is free for everyone. Membership unlocks the companion chapter and the complete Step 1 style question block for this and other published lessons.
Unlock chapters & practiceAlready a member? Sign in
TRY THE PRACTICE EXPERIENCE
SAMPLE QUESTIONApply the idea.
Choose an answer, then see the reasoning. The full question block is included with membership.
A patient with inflammatory bowel disease has marked improvement after infliximab. Several months later, he develops disseminated tuberculosis. An archived pretreatment specimen shows evidence of prior Mycobacterium tuberculosis infection. His circulating lymphocyte count remains within the reference range.